Biosimilars are gaining U.S. momentum even as patent thickets keep triggering legal fights, small biotechs are feeling the pressure of the FDA’s faster-moving approval environment,...
The Biggest Challenge Is Not Lack of Information In the current healthcare environment, new drugs are being approved by the FDA daily. Imagine a healthcare provider...
The FDA is escalating its ongoing push for transparency and tougher enforcement, including publicizing complete response letters, seeking new authority over DTC drug advertising, and...